Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Mar 30, 2026
NIO Inc. (NIO): +12.5% Gain in 30 Days on Profit Milestone and Strong Deliveries

NIO Inc. (NIO): +12.5% Gain in 30 Days on Profit Milestone and Strong Deliveries

Key Takeaways

  • NIO stock rose approximately +12.5% over the last 30 days, driven by its first-ever quarterly profit, record deliveries, and analyst upgrades.
  • Over the past quarter, the stock was relatively flat at -0.56%, reflecting volatility from EV sector pressures offset by strong earnings momentum.
  • Key catalysts include Q4 2025 earnings beat with 76% revenue growth, expanding vehicle margins to 18.1%, and positive guidance for 40-50% delivery growth in 2026.
  • Analyst sentiment shifted positively with upgrades from HSBC and Nomura, boosting market confidence in NIO's volume growth and cost controls.
  • China EV market demand and new model launches like ES9 and ONVO L80 supported price recovery amid competitive pressures.

Understanding NIO Inc. (NIO) and Its Place in the EV Market

NIO Inc. (NIO) stands out as a leading Chinese electric vehicle manufacturer focused on premium smart EVs. The company designs, develops, and sells high-end battery electric vehicles, bolstered by its Battery-as-a-Service model that lets customers swap batteries at stations rather than owning them. In the cutthroat Chinese EV space, NIO competes directly with firms like XPEV and LI.

From what I see, its improving gross margins and rising delivery volumes go a long way toward explaining the recent stock movements. NIO benefits from China's EV subsidies targeting mid-to-high-end models, along with a multi-brand approach—premium NIO vehicles alongside more affordable ONVO options—that sets it up for expansion. That said, profitability hurdles and ongoing price wars have kept things volatile.

NIO Stock Performance: 30-Day Rise vs. Quarterly Flatline

In the last 30 days, NIO stock advanced +12.5%, shifting from about $4.72 to a recent close of $5.31. The move was volatile and trend-led, with a peak near $6.21 mid-month before some retracement, all tied to earnings optimism.

Looking at the past quarter, returns came in nearly flat at -0.56%, as shares traded range-bound around $5. We saw early dips from sector challenges, a post-earnings surge, and then consolidation with broader market swings.

Key Drivers Behind NIO's 30-Day Stock Surge

The big spark came on March 10, 2026, with NIO's unaudited Q4 2025 and full-year results—the company's first quarterly net profit on a non-GAAP basis, ranging from $104-179 million. This built on record deliveries of 124,807 vehicles, up 72% year-over-year, and revenue growth of 76% to $4.95 billion. Vehicle gross margins reached 18.1%, a sign of solid cost management and a better product mix.

Analysts piled on with upgrades: HSBC moved to Buy with a $6.80 target on March 13, pointing to clear 2026 volume growth; Nomura followed with a Buy at $6.60. February 2026 delivery numbers rose 58% year-over-year, keeping the momentum alive. I also checked this using Tickeron’s AI Screener to gauge how NIO stacks up against industry peers.

Sentiment turned more positive with recovering China EV demand and easier trade conditions, though profit-taking led to some late-month pullbacks.

What Shaped NIO's Performance Over the Quarter

The quarter's even keel reflected a mix of EV sector headwinds—fierce price competition and fading subsidies—against NIO's operational improvements. Early softness tied to reduced Q4 delivery guidance (120k-125k units) and China's macroeconomic strains, like softer consumer spending.

A February 5 profit alert kicked off gains, validated by the March earnings. Institutional backing grew through a RMB2.26 billion financing deal, and hitting over 1 million cumulative deliveries added to the confidence. New brands like Firefly and ONVO helped volumes hold up against competitors, even as U.S.-China trade issues limited the upside.

In my view, the earnings strength and margin gains tipped the scales toward stability despite the drags.

Trending AI Robots

As someone who relies on data-driven tools for my analysis, I often turn to Tickeron’s Trending AI Robots page. It highlights the platform's top-performing AI trading bots out of hundreds, which scan thousands of tickers using various strategies, timeframes, and metrics like win rate, profit factor, and drawdown. These picks are tailored to current market dynamics, making them useful for spotting automated signals on names like NIO—whether for short-term trades or longer trends. It's a practical way to incorporate proven automation into stock research.

What's Next for NIO Stock: Key Factors to Track

One thing that stands out is the need to watch Q1 2026 deliveries, guided at 80,000-83,000 units for 90-97% year-over-year growth, plus the full-year outlook of 40-50%. Next earnings will shed light on margin durability in a price-war environment.

Broader trends, such as China EV subsidies for premium models and launches like the ES9, ES7, ONVO L80, and a large SUV, could lift volumes. Macro elements—interest rates, trade policies, and Chinese consumer demand—will play a big role too.

Progress on proprietary chips, BaaS growth, and risks like competition and a debt-to-equity ratio above 2.0 will influence the path forward. I'm watching these closely for signals on sustained momentum.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

Related Ticker: NIO

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


NIO in upward trend: price may jump up because it broke its lower Bollinger Band on September 29, 2026

NIO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 33 of 35 cases where NIO's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for NIO just turned positive on September 21, 2026. Looking at past instances where NIO's MACD turned positive, the stock continued to rise in 37 of 49 cases over the following month. The odds of a continued upward trend are 76%.

Following a +1.64% 3-day Advance, the price is estimated to grow further. Considering data from situations where NIO advanced for three days, in 204 of 260 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 25, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NIO as a result. In 79 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NIO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

The Aroon Indicator for NIO entered a downward trend on September 24, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 72 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.859) is normal, around the industry mean (8.703). P/E Ratio (0.000) is within average values for comparable stocks, (493.775). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.450). Dividend Yield (0.000) settles around the average of (0.017) among similar stocks. P/S Ratio (0.513) is also within normal values, averaging (2.589).

The Tickeron Price Growth Rating for this company is 88 (best 1 - 100 worst), indicating slightly worse than average price growth. NIO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NIO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

Notable companies

The most notable companies in this group are Tesla (NASDAQ:TSLA), General Motors Company (NYSE:GM), Ford Motor Company (NYSE:F), NIO Inc. (NYSE:NIO).

Industry description

Automobiles continue to be arguably the most popular form of passenger travel in the U.S., and major automobile makers have revenues and market capitalizations running into multi-billions. In recent years, the industry has been experiencing some path-breaking innovations like electric vehicles and self-driving technology. While there are long-standing companies like General Motors, Ford, and Toyota Motors operating in this space, there are also emerging/rapidly growing players like Tesla – which has had a major role in the growing popularity of the electric vehicle market. With technological advancements taking steam in the auto space, we’ve also witnessed collaborations (or talks of potential partnerships) of carmakers with tech behemoths like Google’s subsidiary, Waymo.

Market Cap

The average market capitalization across the Motor Vehicles Industry is 69.67B. The market cap for tickers in the group ranges from 669 to 1.41T. TSLA holds the highest valuation in this group at 1.41T. The lowest valued company is PEVM at 669.

High and low price notable news

The average weekly price growth across all stocks in the Motor Vehicles Industry was -7%. For the same Industry, the average monthly price growth was -20%, and the average quarterly price growth was -27%. SEV experienced the highest price growth at 6%, while DCX experienced the biggest fall at -68%.

Volume

The average weekly volume growth across all stocks in the Motor Vehicles Industry was 17%. For the same stocks of the Industry, the average monthly volume growth was -9% and the average quarterly volume growth was -27%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 60
Price Growth Rating: 73
SMR Rating: 86
Profit Risk Rating: 92
Seasonality Score: -5 (-100 ... +100)
View a ticker or compare two or three
NIO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of electric cars

Industry MotorVehicles

Industry
Motor Vehicles
Address
No. 1355, Caobao Road
Phone
+86 2169082018
Employees
35032
Web
https://www.nio.com
Interact to see
Advertisement
MRSH stock declined approximately -9% over the past 30 days, driven by sector-wide AI disruption fears and analyst downgrades. Over the past quarter, the stock fell around -7%, amid softening insurance rates and declining fiduciary interest income.
MCO stock declined approximately -9% over the last 30 days amid profit-taking, insider selling, and sector-wide concerns in financial data analytics. Over the past quarter, shares fell around -18%, reflecting a correction from January highs despite strong Q4 2025 earnings. Key drivers include post-earnings selloff after Q4 results, analyst price target cuts, and broader market volatility in credit ratings sector.
SNOW stock declined approximately -9% over the last 30 days, from around $168 to $153, amid post-earnings profit-taking and analyst caution despite strong results. Over the past quarter, the stock fell about -31%, from near $223, reflecting broader sector pressures and valuation concerns in cloud software.
WDS stock surged +24% over the past 30 days, driven by a sharp rally in oil and LNG prices amid Middle East supply disruptions, including Strait of Hormuz issues and strikes on Qatar's Ras Laffan facility. Over the past quarter, the stock climbed +55%, reflecting sustained energy market volatility and Woodside's strong production from assets like Sangomar and Pluto LNG.
HMC stock declined -19% over the past 30 days amid major setbacks in EV strategy, including cancellation of North American EV models and up to $15.7 billion in related losses. Over the past quarter, shares fell -18%, driven by persistent auto segment weakness, tariff impacts, and revised FY2026 forecasts to a net loss. Key catalysts include March EV reassessment announcement causing a 5%+ drop, Q3 earnings beat overshadowed by one-time charges and guidance concerns, and Sony-Honda JV EV project halt.
EL stock plunged approximately -39% over the past 30 days amid merger discussions with Puig, tariff pressures, and restructuring costs, marking a highly volatile period. Over the past quarter, the stock is down around -37%, reflecting broader sector headwinds despite earlier quarterly earnings beats. Key drivers include confirmation of potential business combination with Puig sparking uncertainty, ongoing $100 million tariff impacts, and elevated restructuring expenses.
ESLT stock rose +13% over the past 30 days, driven primarily by a blowout Q4 2025 earnings report with revenue up 11% and EPS beating estimates by over 10%. Over the past quarter, shares surged +52%, fueled by a record $28.1 billion order backlog, up significantly year-over-year, amid heightened global defense demand. Geopolitical tensions in the Middle East boosted demand for Elbit's systems, alongside major contract wins totaling hundreds of millions from international clients.
EQT stock rose approximately +10% over the last 30 days, driven by strong Q4 2025 earnings beat, robust free cash flow guidance for 2026, and analyst price target increases. Over the past quarter, shares gained around +23%, fueled by operational efficiencies, natural gas price recovery, and positive sector sentiment amid LNG demand growth.
Robin Energy Ltd is a Cyprus-based shipping company focused on ocean and deep-sea freight transportation. As a holding entity, it acquires, owns, charters, and manages oceangoing tanker vessels worldwide. The core of its business lies in energy transportation services, mainly through handysize tankers and LPG carriers. In the competitive marine shipping industry, RBNE positions itself as a growth-oriented player, expanding its fleet and locking in multi-year charters. Recent developments, such as vessel acquisitions and Bitcoin treasury allocations, leave it exposed to shipping cycles and alternative asset volatility. From what I see, this mix contributes to the erratic stock price behavior we've observed amid shifting global energy demand and freight rates.
NG stock plunged -42% over the past 30 days amid sharp declines from mid-March peaks around $14, driven by profit-taking after a multi-year rally and sector-wide weakness in gold mining stocks. Over the past quarter, the stock is down -14%, reflecting volatility from early-year gains tied to financing successes offset by recent macro pressures and permitting concerns. Key drivers include gold price fluctuations due to interest rate expectations, profit-taking post-240%+ annual surge, and no immediate production revenue despite Donlin Gold project advancements.
CRBU stock declined approximately -10% over the past 30 days, reflecting volatility amid clinical updates and financing concerns. Over the past quarter, the stock rose about +12%, driven by positive earnings beats and pipeline progress. Key drivers include Q4 2025 earnings beat, vispa-cel Phase 3 plans, but offset by cash burn and need for additional capital.
Shares of Viridian Therapeutics (VRDN) are down approximately 32% in premarket trading on March 30, 2026, against a prior closing price of $27.39 on March 27, 2026, implying a premarket price near $18.63. The primary catalyst is the release of topline Phase 3 REVEAL-1 clinical trial data for elegrobart (VRDN-003) in patients with active thyroid eye disease (TED), long anticipated as the company's most critical near-term de-risking event.
SYY shares are trading approximately -6.40% lower in premarket trading on March 30, 2026, from a prior close of $81.80 to roughly $76.56. The primary catalyst is Sysco's announcement of a $29.1 billion definitive agreement to acquire Jetro Restaurant Depot, one of the nation's largest Cash & Carry food wholesalers.
Northwest Biotherapeutics, Inc. (NWBO) is a clinical-stage biotechnology company focused on developing personalized immune therapies, primarily dendritic cell-based vaccines under its DCVax platform. The company's lead candidate, DCVax-L, targets glioblastoma multiforme (GBM), a lethal brain cancer, following completion of a Phase III trial. DCVax-Direct addresses inoperable solid tumors, with Phase I/II data available. NWBO operates in the competitive immunotherapy sector against players like large-cap biotechs, relying on a proprietary manufacturing process for cost-effective production.
FingerMotion, Inc. (FNGR) operates as a mobile data specialist, delivering mobile payment and recharge platform solutions mainly in China. The company's core revolves around telecommunication products and services, such as top-up recharges, data plans, SMS and MMS services, big data insights for consumer behavior analysis, and rich communication services (RCS) platforms. It also provides value-added products through partnerships with telecom providers and e-commerce platforms.
NIO Inc. (NIO) stands out as a leading Chinese electric vehicle manufacturer focused on premium smart EVs. The company designs, develops, and sells high-end battery electric vehicles, bolstered by its Battery-as-a-Service model that lets customers swap batteries at stations rather than owning them. In the cutthroat Chinese EV space, NIO competes directly with firms like XPEV and LI.
Xcel Energy Inc. (XEL) stands out as a major U.S. electric and natural gas utility, serving about 3.7 million electric and 2.2 million natural gas customers across eight states, mainly in the Midwest and West. The company focuses on regulated utilities, handling electricity generation, transmission, and distribution, while increasingly prioritizing renewable sources like wind and solar. Its model centers on steady, regulated returns from infrastructure investments, backed by rate cases and recovery mechanisms.
Occidental Petroleum Corporation (OXY) stands out as a leading independent energy producer, with a primary focus on hydrocarbon exploration and production. The company has significant operations in the Permian Basin, one of the U.S.'s most productive oil regions, along with assets in the Rockies, Latin America, and the Middle East. Its business model emphasizes efficient drilling, low-cost production, and carbon capture initiatives aimed at long-term sustainability.
The ProShares UltraShort Bloomberg Natural Gas (KOLD) is a leveraged inverse exchange-traded fund that seeks daily investment results, before fees and expenses, corresponding to two times the inverse (-2x) of the daily performance of the Bloomberg Natural Gas Subindex. This subindex reflects the natural gas segment of the commodities market by tracking futures contracts, primarily the second-month Henry Hub natural gas futures, weighted by liquidity and production. The fund does not invest directly in physical natural gas but uses derivatives like futures contracts and swaps to achieve its objective.
Shares of United Therapeutics (UTHR) are surging approximately +17% in premarket trading on Monday, March 30, 2026, with the market not yet open. The primary catalyst is a landmark Phase 3 clinical trial announcement: the TETON-1 pivotal study of nebulized Tyvaso® (treprostinil) met its primary endpoint for treating idiopathic pulmonary fibrosis (IPF), exceeding the already impressive treatment effects seen in the previously completed TETON-2 study.